Lispan Pharmaceuticals Private Limited - Company Profile

It is a trading private limited company based in Malappuram, Kerala, India, established in 2010.
2010 Malappuram, Kerala, India Struck Off
Last Updated:
Access Report
About Lispan Pharmaceuticals Private Limited

Lispan Pharmaceuticals Private Limited, a struck off private limited company, was established on 16 April 2010 in Malappuram, Kerala, India. Engaging in other wholesale within the trading sector, it holds CIN: U24230KL2010PTC025854. Registered under ROC Roc Ernakulam. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.

Its leadership includes Chempalakkattil Mohamed Ayisha (Director), Suhail Nurukku Parambil (Managing Director). Its latest AGM occurred on 30 September 2015, with the balance sheet filed on 31 March 2015. It is based at Ix/413 J, Vps Complex Pookarathara,Edappal, Malappuram, Kerala, 679576.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24230KL2010PTC025854

  • Registration Number

    025854

  • Incorporation Date

    16 April 2010

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹0.50 M

  • ROC Code

    Roc Ernakulam

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.50 M
  • Company Age 15 Year, 10 Months
  • Last Filing with ROC 31 Mar 2015
Company report

Lispan Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Lispan Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Lispan Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Chempalakkattil Mohamed Ayisha Director 16 Apr 2010 Current
Suhail Nurukku Parambil Managing Director 16 Apr 2010 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Lispan Pharmaceuticals.

Enhance accessibility to Lispan Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Lispan Pharmaceuticals revenue growth over time
Lispan Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Lispan Pharmaceuticals?

Unlock access to Lispan Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Lispan Pharmaceuticals?

Unlock and access historical data on people associated with Lispan Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Lispan Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lispan Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Lispan Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Lispan Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2015 as per latest MCA records. was documented.

  • Balance Sheet

    Lispan Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2015 with Roc Ernakulam. was recorded as a recent event.

  • Director Appointment

    Chempalakkattil Mohamed Ayisha was appointed as a Director was appointed as a Director on 16 Apr 2010 & has been associated with this company since 15 years 10 months . was recorded as a recent event.

  • Director Appointment

    Progress on Suhail Nurukku Parambil was appointed as a Managing Director was appointed as a Managing Director on 16 Apr 2010 & has been associated with this company since 15 years 10 months . was documented.

  • Company Incorporation

    The activity Lispan Pharmaceuticals Private Limited was registered on 16 Apr 2010 with Roc Ernakulam & aged 15 years 10 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Lispan Pharmaceuticals Private Limited?

The CIN of Lispan Pharmaceuticals Private Limited is U24230KL2010PTC025854.

Where is Lispan Pharmaceuticals Private Limited headquartered?

Lispan Pharmaceuticals Private Limited is headquartered at Ix/413 J, Vps Complex Pookarathara,Edappal, Malappuram, Kerala, 679576.

When was Lispan Pharmaceuticals Private Limited incorporated?

Lispan Pharmaceuticals Private Limited was incorporated on 16 April 2010.

Who are the current directors of Lispan Pharmaceuticals Private Limited?

The current directors of Lispan Pharmaceuticals Private Limited are

What is the primary industry of Lispan Pharmaceuticals Private Limited?

The primary industry of Lispan Pharmaceuticals Private Limited is Trading.

Is Lispan Pharmaceuticals Private Limited a listed company?

Lispan Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Lispan Pharmaceuticals Private Limited?

The authorized capital of Lispan Pharmaceuticals Private Limited is ₹0.50 M, and the paid-up capital is ₹0.50 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available